NF Midwest Co-Funds New NF2 Gene Therapy Project

Thanks to the support of our donors, NF Midwest is proud to be one of four NF organizations collaborating to fund a new  NF2 Gene Therapy project.

NF Midwest, NF2 BioSolutions, NF Northeast, and NF Michigan have combined forces to fund a USD$100,000 Gene therapy project at Dr. Wade Clapp’s Lab at the Indiana University.

This project will test several vectors on NF2 mice. (Vectors are sort of the vehicle that delivers the material to change a gene to the correct cells – Learn More About Vectors ). These vectors were designed by two separate labs at both University of Massachusetts and Nationwide Children’s Hospital. The UMass project was funded last year by another collaborative USD$65,000 grant from NF Northeast, NF Midwest, and NF2 BioSolutions. The project at Nationwide Children’s Hospital was funded by a three year USD$330,000 grant from NF2 BioSolutions.

Recent Posts

  • What Is an ABLE Account?

    If you or someone you love is living with NF, you know the costs can add up: therapies, assistive devices, specialists, and more. An ABLE account is a savings tool built to help with exactly that. The Basics ABLE stands for Achieving a Better Life Experience. It’s a tax-advantaged savings account for people with disabilities.... Read More
  • Nothing to Fear: A Children’s Book on NF

    For young children with neurofibromatosis, medical appointments can feel big, unfamiliar, and sometimes scary. An eye exam, an MRI, a doctor’s visit, or even the mention of a needle can bring up questions that are hard for a small child to understand — especially between the ages of 3 and 7, when imagination is strong... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *